- Home
- XRX vs FENC Comparison
XRX vs FENC Comparison
Compare XRX & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XRX | FENC |
|---|---|---|
| Founded | 1906 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.6M | 276.3M |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | XRX | FENC |
|---|---|---|
| Price | $2.24 | $7.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $3.50 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 2.9M | 177.2K |
| Earning Date | 01-29-2026 | 03-09-2026 |
| Dividend Yield | ★ 4.35% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,607,000,000.00 | $38,790,000.00 |
| Revenue This Year | $15.48 | N/A |
| Revenue Next Year | $11.05 | $70.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.67 | N/A |
| 52 Week Low | $2.10 | $4.68 |
| 52 Week High | $9.91 | $9.92 |
Technical Indicators
Market Signals| Indicator | XRX | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 37.40 | 52.24 |
| Support Level | $2.10 | $7.35 |
| Resistance Level | $2.60 | $7.84 |
| Average True Range (ATR) | 0.14 | 0.31 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 21.43 | 52.63 |
Price Performance
Historical ComparisonAbout XRX Xerox Holdings Corporation
Xerox Holdings Corp is an original equipment manufacturing and software company. Xerox operates in one segment--design, development, and sale of printing technology and related solutions--while deriving 60% of its revenue from the U.S. and 40% from international markets. The company is an OEM of multifunction printers, or MFPs (printers that can print, copy, and scan), focusing on large enterprise markets. Apart from equipment, the company provides post-sales services like managed print services help to bring smart servicing and efficiencies to how employers use their print/copy equipment. Xerox is attempting to enter new markets like digital print packaging solutions and printed electronics.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.